JP2021528411A5 - - Google Patents

Info

Publication number
JP2021528411A5
JP2021528411A5 JP2020570569A JP2020570569A JP2021528411A5 JP 2021528411 A5 JP2021528411 A5 JP 2021528411A5 JP 2020570569 A JP2020570569 A JP 2020570569A JP 2020570569 A JP2020570569 A JP 2020570569A JP 2021528411 A5 JP2021528411 A5 JP 2021528411A5
Authority
JP
Japan
Prior art keywords
lif
amino acid
acid sequence
seq
sequence shown
Prior art date
Application number
JP2020570569A
Other languages
English (en)
Japanese (ja)
Other versions
JP7570929B2 (ja
JPWO2019243893A5 (https=
JP2021528411A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/000756 external-priority patent/WO2019243893A1/en
Publication of JP2021528411A publication Critical patent/JP2021528411A/ja
Publication of JPWO2019243893A5 publication Critical patent/JPWO2019243893A5/ja
Publication of JP2021528411A5 publication Critical patent/JP2021528411A5/ja
Application granted granted Critical
Publication of JP7570929B2 publication Critical patent/JP7570929B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020570569A 2018-06-18 2019-06-17 Ｌｉｆを定量化する方法及びその使用 Active JP7570929B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18382433.3 2018-06-18
EP18382433 2018-06-18
PCT/IB2019/000756 WO2019243893A1 (en) 2018-06-18 2019-06-17 Methods of quantifying lif and uses thereof

Publications (4)

Publication Number Publication Date
JP2021528411A JP2021528411A (ja) 2021-10-21
JPWO2019243893A5 JPWO2019243893A5 (https=) 2022-06-24
JP2021528411A5 true JP2021528411A5 (https=) 2022-06-24
JP7570929B2 JP7570929B2 (ja) 2024-10-22

Family

ID=62716028

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020570569A Active JP7570929B2 (ja) 2018-06-18 2019-06-17 Ｌｉｆを定量化する方法及びその使用

Country Status (5)

Country Link
US (1) US20210190798A1 (https=)
EP (1) EP3806960A1 (https=)
JP (1) JP7570929B2 (https=)
CN (1) CN112654395A (https=)
WO (1) WO2019243893A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020354255A1 (en) 2019-09-29 2022-04-21 Jacobio Pharmaceuticals Co., Ltd. Binding molecule specific for LIF and use thereof
EP4069736A1 (en) * 2019-12-04 2022-10-12 MedImmune Limited Antibodies against lif and uses thereof
CN116298320B (zh) * 2023-03-31 2025-07-11 深圳迈瑞生物医疗电子股份有限公司 检测白血病抑制因子的试剂盒及检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011057144A2 (en) * 2009-11-06 2011-05-12 La Jolla Institute For Allergy And Immunology Methods for modulating lif activity, treating immune disorders and diseases, and stimulatings immune responses
WO2015040243A2 (en) * 2013-09-23 2015-03-26 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for targeting tumor microenvironment and for preventing metastasis
US10583191B2 (en) * 2016-12-19 2020-03-10 Mosaic Biomedicals Slu Antibodies against LIF and uses thereof

Similar Documents

Publication Publication Date Title
AU2010298036B2 (en) Screening methods
JP2022115986A5 (https=)
US10114028B2 (en) Biomarkers for pneumonia and acute decompensated heart failure
JP2016533395A5 (https=)
JP6138780B2 (ja) 癌の検出および診断のための抗体ｉ−３８５９の使用
JP2021528411A5 (https=)
Weeraratne et al. Development of a biosensor-based immunogenicity assay capable of blocking soluble drug target interference
US20240092925A1 (en) Cd5-targeting fully humanized antibody
JP2017524362A5 (https=)
KR102017241B1 (ko) C-반응성 단백질에 특이적으로 결합하는 항체 및 이의 용도
Park et al. Evolutionary identification of affinity peptides for the detection of sepsis biomarker procalcitonin
JP2007513873A5 (https=)
Martin et al. Surface plasmon resonance investigations of human epidermal growth factor receptor 2
JP2005522228A5 (https=)
JP2022506108A5 (https=)
JPWO2019243893A5 (https=)
JPWO2024070874A5 (https=)
CN115991776A (zh) 一种靶向cd7的全人源抗体及其应用
CN114891108A (zh) 一种靶向bcma的全人源抗体及其应用
WO2020241812A1 (ja) 抗オキシトシンモノクローナル抗体及び該抗体を含むキット
CA2771954A1 (en) Pneumonia biomarkers
Li et al. Selection of potential cytokeratin-18 monoclonal antibodies following IGH repertoire evaluation in mice
JP2020501162A5 (https=)
WO2018213680A1 (en) Diagnostic antibodies and methods of use
WO2017201440A1 (en) Anti-ascl1 antibodies and methods of use